Effective strategies for suicide prevention in New Zealand: A review of the evidence

New Zealand Medical Journal

Volumn 120, Issue 1251, 2007, Pages

  Beautrais, Annette L ^a   Fergusson, David ^a   Coggan, Carolyn ^b   Collings, Catherine ^c   Doughty, Carolyn ^a   Ellis, Pete M ^c   Hatcher, Simon ^d   Horwood, L John ^a   Merry, Sally N ^d   Mulder, Roger ^a   Poulton, Richie ^e   Surgenor, Lois ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b Safe Communities Foundation New Zealand   (New Zealand)

^c UNIVERSITY OF OTAGO   (New Zealand)

^d UNIVERSITY OF AUCKLAND   (New Zealand)

^e UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CLOZAPINE; LITHIUM; OLANZAPINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR;

ACADEMIC ACHIEVEMENT; ALCOHOL CONSUMPTION; AWARENESS; BEREAVEMENT; BIPOLAR DISORDER; CLASSIFICATION; CLINICAL TRIAL; COMPETENCE; CONCEPTUAL FRAMEWORK; DEPRESSION; EVIDENCE BASED MEDICINE; HUMAN; MASS MEDIUM; MEDICAL EDUCATION; MEDICAL RESEARCH; MENTAL DISEASE; MENTAL HEALTH SERVICE; NEW ZEALAND; OUTCOMES RESEARCH; PATIENT COUNSELING; PATIENT EDUCATION; PHYSICIAN; PREVENTIVE MEDICINE; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; PSYCHOSOCIAL CARE; PSYCHOTHERAPY; PUBLIC HEALTH SERVICE; RECALL; REVIEW; SCHOOL HEALTH SERVICE; SCREENING TEST; SKILL; SOCIAL SUPPORT; SUICIDAL BEHAVIOR; SUICIDAL IDEATION; SUICIDE; SUICIDE ATTEMPT; HEALTH CARE PLANNING; HEALTH EDUCATION; MASS SCREENING; METHODOLOGY; ORGANIZATION AND MANAGEMENT;

EVIDENCE-BASED MEDICINE; HEALTH EDUCATION; HEALTH PLAN IMPLEMENTATION; HUMANS; MASS SCREENING; MENTAL DISORDERS; MENTAL HEALTH SERVICES; NEW ZEALAND; SOCIAL SUPPORT; SUICIDE;

EID: 34147109779     PISSN: None     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Review

References (76)

1. Mann JJ, Apter A, Bertolote J, et al. Suicide prevention strategies. A systematic review. JAMA. 2005;294:2064-74.
2. Bruce ML, Ten Have TR, Reynolds CF, 3rd, et al. Reducing suicidal ideation and depressive symptoms in depressed older primary care patients: a randomized controlled trial. JAMA. 2004;291:1081-91.
3. Hirschfeld RM, Keller MB, Panico S, et al. The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression. JAMA. 1997;277:333-40.
4. Luoma JB, Martin CE, Pearson JL. Contact with mental health and primary care providers before suicide: A review of the evidence. Am J Psychiatry. 2002;159:909-16.
5. Gilbody S, Whitty P, Grimshaw J, Thomas R. Educational and organizational interventions to improve the management of depression in primary care: a systematic review. [see comment]. JAMA. 2003;289:3145-5311.
6. Kreitman N. The coal gas story: United Kingdom suicide rates, 1960-71. Br J Prev Soc Med. 1976;30:86-93.
7. Beautrais AL, Fergusson DM, Horwood LJ. Firearms legislation and reductions in firearm-related suicide deaths in New Zealand. Aust NZ Psychiatry. 2006;40:253-9.
8. Amos T, Appleby L, Kiernan K. Changes in rates of suicide by car exhaust asphyxiation in England and Wales. Psychol Med. 2001;31:935-39.
9. Ohberg A, Lonnqvist J, Sarna S, et al. Trends and availability of suicide methods in Finland: Proposals for restrictive measures. Br. J. Psychiatry. 1995;166:35-43.
10. Hawton K. United Kingdom legislation on pack sizes of analgesics: Background, rationale, and effects on suicide and deliberate self-harm. Suicide Life Threat Behav. 2002;32:223-9.
11. Beautrais A, L. Effectiveness of barriers at suicide jumping sites: A case study. Aust NZ Psychiatry. 2001;35:557-62.
12. Oliver RG, Hetzel BS. Rise and fall of suicide rates in Australia: Relation to sedative availability. Med J Aust. 1972;2:919-23.
13. Kapur S, Mieczkowski T, Mann JJ. Antidepressant medications and the relative risk of suicide attempt and suicide. JAMA. 1992;268:3441-5.
14. Knox KL, Litts DA, Talcott GW, et al. Risk of suicide and related adverse outcomes after exposure to a suicide prevention programme in the US Air Force: Cohort study. BMJ. 2003;327:1-5.
15. Beautrais AL. Subsequent mortality in medically serious suicide attempts: A 5 year follow-up. Australian & New Zealand Journal of Psychiatry. 2003;37:595-9.
16. Dieserud G, Loeb M, Ekeberg O. Suicidal behavior in the municipality of Baerum, Norway: A 12-year prospective study of parasuicide and suicide. Suicide Life Threat Behav. 2000;30:61-73.
17. Carter GL, Clover K, Whyte IM, et al. Postcards from the EDge project: Randomised controlled trial of an intervention using postcards to reduce repetition of hospital treated deliberate self poisoning. BMJ. 2005;331:805.
18. Morgan HG, Jones EM, Owen JH. Secondary prevention of non-fatal deliberate self-harm. The green card study. Br. J. Psychiatry. 1993;163:111-2.
19. Thies-Flechtner K, Muller-Oerlinghausen B, Seibert W, et al. Effect of prophylactic treatment on suicide risk in patients with major affective disorders: Data from a randomized prospective trial. Pharmacopsychiat. 1996;29:103-7.
20. Glick ID, Zaninelli R, Hsu C, et al. Patterns of concomitant psychotropic medication use during a 2-year study comparing clozapine and olanzapine for the prevention of suicidal behavior. J. Clin. Psychiatry. 2004;65:679-85.
21. Montgomery SA, Dunner DL, Dunbar GC. Reduction of suicidal thoughts with paroxetine in comparison with reference antidepressants and placebo. European Neuropsychopharmacology. 1995;5:5-13.
22. Angst F, Stassen HH, Clayton PJ, Angst J. Mortality of patients with mood disorders: Follow-up over 34-38 years. J Affective Disord. 2002;68:167-81.
23. Simon GE, Savarino J, Operskalski B, Wang PS. Suicide risk during antidepressant treatment. Am J Psychiatry. 2006;163:41-7.
24. Valuck RJ, Libby AM, Sills MR, et al. Antidepressant treatment and risk of suicide attempt by adolescents with major depressive disorder: a propensity-adjusted retrospective cohort study. CNS Drugs. 2004;18:1119-32.
25. Isacsson G. Suicide prevention - A medical breakthrough? Acta Psychiatr. Scand. 2000;102:113-7.
26. Olfson M, Gameroff MJ, Marcus SC, Waslick BD. Outpatient treatment of child and adolescent depression in the United States. Arch Gen Psychiatry. 2003;60:1236-42.
27. Ludwig J, Marcotte DE. Anti-depressants, suicide, and drug regulation. J Policy Anal Manage. 2005;24:249-72.
28. Gunnell D, Ashby D. Antidepressants and suicide: What is the balance of benefit and harm. BMJ. 2004;329:34-8.
29. Resland S, Bray I, Gunnell D. Relationship between antidepressant sales and secular trends in suicide rates in the Nordic countries. Br. J. Psychiatry. 2006;188:354-8.
30. Healy D. Lines of evidence on the risk of suicide with selective serotonin reuptake inhibitors. Psychother Psychosom. 2003;72:71-9.
31. Food and Drug Administration; 2004. http://www.fda.gov/bbs/topics/ news/2004/new01124.htm
32. Brent DA. Paroxetine and the FDA. J Am Acad Child Adolesc Psychiatry. 2004;43:127-8.
33. Lenzer J. FDA warns that antidepressants may increase suicidality in adults. BMJ. 2005;331:70.
34. Bethesda JL. FDA hearings confirm risks of antidepressants. BMJ. 2004;329:641.
35. Hawton K, Arensman E, Townsend E, et al. Deliberate self harm: Systematic review of efficacy of psychosocial and pharmacological treatments in preventing repetition. BMJ. 1998;317:441-7.
36. Gaynes BN, West SL, Ford CA, et al. Screening for suicide risk in adults: A summary of the evidence for the U.S. Preventive Services Task Force. Ann Int Med. 2004;140:822-35.
37. Brown GK, Ten Have T, Henriques GR, et al. Cognitive therapy for the prevention of suicide attempts: A randomized controlled trial. JAMA. 2005;294:563-70.
38. Links PS, Bergmans Y, Cook M. Psychotherapeutic interventions to prevent repeated suicidal behavior. Brief Treat Crisis Interven. 2003;3:445-64.
39. Motto JA, Bostrom AG. A randomized controlled trial of postcrisis suicide prevention. Psychiatr Serv. 2001;52:828-33.
40. Bateman AW, Fonagy P. Treatment of borderline personality disorder with psychoanalytically oriented partial hospitalization: an 18-month follow-up. Am J Psychiatry. 2001;158:36-42.
41. Huey SJ, Henggeler SW, Rowland MD, et al. Predictors of treatment response for suicidal youth referred for emergency psychiatric hospitalization. Journal of Clinical Child & Adolescent Psychology. 2005;34:582-9.
42. King CA, Kramer A, Preuss L. Youth-nominated support team for suicidal adolescents (Version 1): A randomized controlled trial. Journal of Consulting & Clinical Psychology. 2006;74:199-206.
43. Goldney RD, Fisher LJ, Wilson DH. Mental health literacy: An impediment to the optimum treatment of major depression in the community. J Affective Disord. 2001;64:277-84.
44. Hegerl U, Althaus D, Stefanek J. Public attitudes towards treatment of depression: effects of an information campaign. Pharmacopsychiat. 2003;36:288-91.
45. Stuart H. Fighting stigma and discrimination. Is fighting for mental health. Canadian Public Policy. 2005;XXXI:S21-S28.
46. Shaffer D, Scott M, Wilcox H, et al. The Columbia Suicide Screen: Validity and reliability of a screen for youth suicide and depression. J Am Acad Child Adolesc Psychiatry. 2004;43:71-9.
47. Pollinger-Haas A, Hendin H, Mann JJ. Suicide in college students. American Behavioural Scientist. 2003;46:1224-40.
48. Henkel V, Mergl R, Kohnen R, et al. Identifying depression in primary care: A comparison of different methods in a prospective cohort study. BMJ. 2003;326:200-1.
49. Seeley MF. The role of hotlines in the prevention of suicide. In: Maris RW, Silverman MM, Canetto SS, editors. Review of Suicidology. New York: Guilford, 1997:251-70.
50. Shaffer D, Garland A, Fisher P, et al. Suicide crisis centers: A critical reappraisal with special reference to the prevention of youth suicide. In: Goldston FE, Heinick CM, Pynoos RS, Yager T, editors. Prevention of Mental Health Disturbance in Childhood. New York: APA Press; 1988.
51. Dew MA, Bromet EJ, Brent D, Greenhouse JB. A quantitative literature review of the effectiveness of suicide prevention centers. J. Consult. Clin. Psychol. 1987;55:239-44.
52. Do helplines help suicidal callers? 2nd Asia Pacific Suicide Prevention Conference; 2006 10-12 March 2006; Singapore.
53. Eggert LL, Thompson EA, Herting JR, Nicholas LJ. Reducing suicide potential among high-risk youth: Tests of a school-based prevention program. Suicide Life Threat Behav. 1995;25:276-96.
54. Crane C, Hawton K, Simkin S, Coulter P. Suicide and the media: Pitfalls and prevention. Report on a meeting organized by the Reuters Foundation Program at Green College and University of Oxford Centre for Suicide Research at Green College, Oxford, UK, November 18th, 2003. Crisis. 2005;26:53-8.
55. Ministry of Health. Suicide and the Media: The Reporting and Portrayal of Suicide in the Media. Wellington: Ministry of Health; 1999.
56. American Foundation for Suicide Prevention, American Association of Suicidology, Annenberg Public Policy Center. Reporting on Suicide: Recommendations for the Media. New York: American Foundation for Suicide Prevention; 2001 http://www.afsp.org/education/recommendations/index/ html
57. Pirkis J, Blood W, Beautrais A, et al. Media guidelines on the reporting of suicide. Crisis (in press).
58. Brent DA, Mann JJ. Family genetic studies, suicide, and suicidal behavior. American Journal of Medical Genetics. 2005;133C:13-24.
59. Range LM, Campbell C, Kovac SH, et al. No-suicide contracts: An overview and recommendations. Death Studies. 2002;26:51-74.
60. Farberow NL. The Los Angeles Survivors-After-Suicide program. An evaluation. Crisis. 1992;13:23-34.
61. Pfeffer CR, Jiang H, Kakuma T, et al. Group intervention for children bereaved by the suicide of a relative. J Am Acad Child Adolesc Psychiatry. 2002;41:505-13.
62. Nelson TF, Naimi TS, Brewer RD, Wechsler H. The state sets the rate: The relationship among state-specific college binge drinking, state binge drinking rates, and selected state alcohol control policies. Am J Public Health. 2005;95:441-6.
63. Varnik A, Wasserman D, Dankowicz M, Eklund G. Marked decrease in suicide among men and women in the former USSR during perestroika. Acta Psychiatr. Scand. 1998;98:13-9.
64. Lester D. Effect of changing alcohol laws in Iceland on suicide rates. Psychol Rep. 1999;84:1158.
65. Prosser D, Johnson S, Kuipers E, et al. Mental health, "burnout" and job satisfaction in a longitudinal study of mental health staff. Soc Psychiatry Psychiatr Epidemiol. 1999;34:295-300.
66. Simmonds S, Coid J, Joseph P, et al. Community mental health team management in severe mental illness: A systematic review. Br J Psychiatry. 2001;178:497-502.
67. Fergusson D, Grant H, Horwood LJ, et al. Randomized trial of the Early Start Program of home visitation. Pediatrics, 2005;116: e803-e908. http://pediatrics.org/cgi/doi/10.1542/peds.2005-0948
68. Shaffer D, Garland A, Vieland V, et al. The impact of curriculum-based suicide prevention programs for teenagers. J Am Acad Child Adolesc Psychiatry. 1991;30:588-96.
69. Gould MS, Greenberg T, Velting DM, Shaffer D. Youth suicide risk and preventive interventions: A review of the past 10 years. J Am Acad Child Adolesc Psychiatry. 2003;42:386-405.
70. Gould MS. Suicide and the media. Ann N Y Acad Sci. 2001;932:200-21.
71. Aseltine RHJ, DeMartino R. An outcome evaluation of the SOS Suicide Prevention Program. Am J Public Health. 2004;94:446-51.
72. Chambers DA, Pearson JL, Lubell K, et al. The science of public messages for suicide prevention: A workshop summary. Suicide Life Threat Behav. 2005;35:134-45.
73. Kelly K, Knudson MP. Are no-suicide contracts effective in preventing suicide in suicidal patients seen by primary care physicians? Arch Fam Med. 2000;9:1119-21.
74. Shaffer D, Pfeffer CR, Bernet W, et al. Practice parameter for the assessment and treatment of children and adolescents with suicidal behavior. J Am Acad Child Adolesc Psychiatry. 2001;40:24S-51S.
75. Frankel FH. Discovering new memories in psychotherapy - childhood revisited, fantasy, or both? N. Engl. J. Med. 1995;333:591-4.
76. Fetkewicz J, Sharma V, Merskey H. A note on suicidal deterioration with recovered memory treatment. J Affective Disord. 2000;58:155-9.